ArticleOncology reports2021

Use of miR‑145 and testicular nuclear receptor 4 inhibition to reduce chemoresistance to docetaxel in prostate cancer.

Jin Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.